|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/21/24 Tandem Diabetes Care Inc. 10-K 12/31/23 95:10M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.04M
2: EX-4.2 EX-4.2 Description of Capital Stock HTML 34K
3: EX-10.25 EX-10.25 Employee Offer Letter HTML 39K
4: EX-21.1 EX-21.1 Subsidiaries of the Registrant HTML 26K
5: EX-23.1 EX-23.1 Consent HTML 27K
10: EX-97 EX-97 Clawback Policy HTML 46K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 27K
16: R1 Cover Page HTML 92K
17: R2 Audit Information HTML 31K
18: R3 Consolidated Balance Sheets HTML 129K
19: R4 Consolidated Balance Sheets (Parenthetical) HTML 36K
20: R5 Consolidated Statements of Operations and HTML 115K
Comprehensive Income (Loss)
21: R6 Condensed Consolidated Statements of Stockholders? HTML 101K
Equity
22: R7 Consolidated Statements of Cash Flows HTML 135K
23: R8 Organization and Basis of Presentation HTML 33K
24: R9 Summary of Significant Accounting Policies HTML 122K
25: R10 Short-Term Investments HTML 77K
26: R11 Composition of Certain Financial Statement Items HTML 70K
27: R12 Fair Value Measurements HTML 70K
28: R13 Leases HTML 67K
29: R14 Debt HTML 60K
30: R15 Stockholders' Equity HTML 140K
31: R16 Employee Benefits HTML 29K
32: R17 Income Taxes HTML 111K
33: R18 Business Segment and Geographic Information HTML 45K
34: R19 Acquisitions HTML 33K
35: R20 Commitments and Contingencies HTML 33K
36: R21 Fourth Quarter Financial Data (Unaudited) HTML 40K
37: R22 Subsequent Event HTML 28K
38: R23 Organization and Basis of Presentation (Policies) HTML 125K
39: R24 Summary of Significant Accounting Policies HTML 97K
(Tables)
40: R25 Short-Term Investments (Tables) HTML 76K
41: R26 Composition of Certain Financial Statement Items HTML 78K
(Tables)
42: R27 Fair Value Measurements (Tables) HTML 65K
43: R28 Leases (Tables) HTML 60K
44: R29 Debt (Tables) HTML 44K
45: R30 Stockholders' Equity (Tables) HTML 139K
46: R31 Income Taxes (Tables) HTML 110K
47: R32 Business Segment and Geographic Information HTML 38K
(Tables)
48: R33 Fourth Quarter Financial Data (Unaudited) (Tables) HTML 39K
49: R34 Organization and Basis of Presentation (Details) HTML 30K
50: R35 Summary of Significant Accounting Policies - HTML 67K
Additional Information (Details)
51: R36 Summary of Significant Accounting Policies - HTML 43K
Customers Accounted for 10% or More (Detail)
52: R37 Summary of Significant Accounting Policies - HTML 42K
Reconciliation of Change in Estimated Warranty
Liabilities (Details)
53: R38 Summary of Significant Accounting Policies - HTML 56K
Numerator and Denominator of the Basic and Diluted
Net Income (Loss) Per Share Computations (Details)
54: R39 Summary of Significant Accounting Policies - HTML 42K
Anti-Dilutive Securities (Details)
55: R40 Short-Term Investments - Estimated Fair Value of HTML 52K
Short-Term Investments (Details)
56: R41 Short-Term Investments - Contractual Maturities of HTML 48K
Available - For- Sale Debt Securities (Details)
57: R42 Composition of Certain Financial Statement Items - HTML 35K
Accounts Receivable (Details)
58: R43 Composition of Certain Financial Statement Items - HTML 34K
Reconciliation of Change in Estimated Allowance
for Doubtful Accounts (Details)
59: R44 Composition of Certain Financial Statement Items - HTML 34K
Inventory (Details)
60: R45 Composition of Certain Financial Statement Items - HTML 43K
Summary of Property and Equipment (Detail)
61: R46 Composition of Certain Financial Statement Items - HTML 36K
Additional Information (Detail)
62: R47 Composition of Certain Financial Statement Items - HTML 35K
Intangible Assets Subject to Amortization
(Details)
63: R48 Fair Value Measurements - Financial Assets and HTML 84K
Liabilities Measured at Fair Value on Recurring
Basis (Details)
64: R49 Leases - Additional Information (Details) HTML 97K
65: R50 Leases - Lease Cost, Lease Term Discount Rate, HTML 39K
Operating Leases (Details)
66: R51 Leases - Future Minimum Payments Under HTML 49K
Non-cancellable Operating Leases (Details)
67: R52 Leases - Lease Payments (Details) HTML 31K
68: R53 Debt - Additional Information (Details) HTML 127K
69: R54 Debt - Components of Convertible Note (Details) HTML 44K
70: R55 Debt - Interest Expense Recognized (Details) HTML 46K
71: R56 Stockholders' Equity -Shares of Common Stock HTML 51K
Reserved for Future Issuance (Details)
72: R57 Stockholders' Equity - Common Stock Warrants HTML 39K
(Details)
73: R58 Stockholders' Equity - Additional Information HTML 101K
(Details)
74: R59 Stockholders' Equity - Summary of Stock Option HTML 81K
Activities for 2006 Plan and 2013 Plan (Detail)
75: R60 Stockholders' Equity - Restricted Stock Units HTML 61K
(RSUs) (Details)
76: R61 Stockholders' Equity - Assumptions Used in HTML 54K
Black-Scholes Option-Pricing Model (Details)
77: R62 Stockholders' Equity - Allocation of Stock-Based HTML 43K
Compensation Expense (Details)
78: R63 Employee Benefits - Additional Information HTML 29K
(Details)
79: R64 Income Taxes - Income (Loss) Before Provision for HTML 36K
Income Taxes (Details)
80: R65 Income Taxes - Schedule of Components of Income HTML 54K
Tax (Details)
81: R66 Income Taxes - Income Tax Expense (Details) HTML 53K
82: R67 Income Taxes - Additional Information (Details) HTML 62K
83: R68 Income Taxes - Schedule of Deferred Tax Assets and HTML 57K
Liabilities (Details)
84: R69 Income Taxes - Schedule of Unrecognized Tax HTML 36K
Benefits (Detail)
85: R70 Business Segment and Geographic Information - HTML 38K
Additional Information (Details)
86: R71 Business Segment and Geographic Information - HTML 38K
Geographical Markets (Details)
87: R72 Acquisitions (Details) HTML 54K
88: R73 Commitments and Contingencies (Details) HTML 31K
89: R74 Fourth Quarter Financial Data (Unaudited) (Detail) HTML 74K
90: R9999 Uncategorized Items - tndm-20231231.htm HTML 45K
92: XML IDEA XML File -- Filing Summary XML 166K
95: XML XBRL Instance -- tndm-20231231_htm XML 2.12M
91: EXCEL IDEA Workbook of Financial Report Info XLSX 184K
12: EX-101.CAL XBRL Calculations -- tndm-20231231_cal XML 255K
13: EX-101.DEF XBRL Definitions -- tndm-20231231_def XML 631K
14: EX-101.LAB XBRL Labels -- tndm-20231231_lab XML 1.94M
15: EX-101.PRE XBRL Presentations -- tndm-20231231_pre XML 1.15M
11: EX-101.SCH XBRL Schema -- tndm-20231231 XSD 182K
93: JSON XBRL Instance as JSON Data -- MetaLinks 571± 871K
94: ZIP XBRL Zipped Folder -- 0001438133-24-000028-xbrl Zip 918K
| Document |
| Name of Entity | State/Country of Organization | ||||
| Capillary Biomedical, LLC | United States | ||||
| Sugarmate, LLC | United States | ||||
| Tandem Diabetes Care Canada, Inc. | Canada | ||||
| Tandem Diabetes Care Europe B.V. | Netherlands | ||||
| Tandem Diabetes Care Switzerland Sarl | Switzerland | ||||